Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid Carcinoma

StatusCompleted
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study Status, Referencesv8
  2. Trial status: Suspended to Completed
    • Study completion date changed from estimate of Sep 2012 to Dec 2012
    v7
  3. Trial status: Recruiting to Suspended Sponsor's reason: interim analysis
    • Primary completion date: Dec 2011
    • Secondary endpoints: details revised at 3 of 3 entries
    • Site details revised at 11 of 11 sites
    v6
  4. Site contacts updated at 1 of 11 sitesv5
  5. Re-verified, no change to tracked fieldsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Site contacts updated at 1 of 11 sitesv3
  2. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine whether association Gemcitabine-Cisplatin is effective in the treatment of penis epidermoid carcinoma loco-regionally advanced or metastatic.
Trial Details
NCT Number NCT00210041
Lead Sponsor Institut Claudius Regaud
Conditions
(from sponsor)		 Genital Neoplasms, Male
Related terms Genital Neoplasms, Male
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov